AMI Organics Ltd.

Financial

	AMI Organics	Supriya Lifescience	Aether Industries
Operational Metrics
Financials
5 yr Average ROE	18.21 %	29.47 %	14.21 %
5yr average Equity Multiplier	1.75	1.48	1.42
5yr Average Asset Turnover Ratio	0.82	0.74	0.5
5yr Avg Net Profit Margin	12.12 %	24.83 %	17.43 %
Price to Book	7.5	6.37	5.04
P/E	74.24	33.1	102.81
5yr Avg Cash Conversion Cycle	58.6 Days	10.2 Days	217.24 Days
Inventory Days	65.78 Days	54.74 Days	132.13 Days
Days Receivable	111.06 Days	55.39 Days	149.84 Days
Days Payable	142.05 Days	115.12 Days	100.24 Days
5yr Average Interest Coverage Ratio	19.71	36.33	20.43
5yr Avg ROCE	22.58 %	37.03 %	16.82 %
5yr Avg Operating Profit Margin	19.73 %	34.97 %	26.4 %
5 yr average Debt to Equity	0.34	0.17	0.27
5yr CAGR Net Profit	9.26 %	10.17 %	-5.41 %
5yr Average Return on Assets	10.12 %	18.81 %	9.01 %
Shareholdings
Promoter Holding	35.96 %	68.3 %	81.77 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-5.09 %	0.06 %	-5.32 %
Change in Mutual Fund Holding (3 Yrs)	10.94 %	-2.68 %	3.27 %

Business

	AMI Organics	Supriya Lifescience	Aether Industries
Product Wise Break-Up	Product Wise Break-Up Pharma Intermediates 79.0 Specialty Chemicals 21.0 Pharmaceuticals 0 2-Methoxy-6-Chlorotoluene (MCT) 0 0 0 0 Thiophene-2-Ethanol (T2E) 0 4-(2-Methoxyethyl) Phenol (4MEP) 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 Bifenthrin Alcohol (BFA) 0 CRAMS 0	Product Wise Break-Up 2-Methoxy-6-Chlorotoluene (MCT) 0 0 0 4-(2-Methoxyethyl) Phenol (4MEP) 0 Bifenthrin Alcohol (BFA) 0 Specialty Chemicals 0 Pharmaceuticals 100.0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 CRAMS 0 0 Pharma Intermediates 0 Thiophene-2-Ethanol (T2E) 0	Product Wise Break-Up 2-Methoxy-6-Chlorotoluene (MCT) 0 0 3-Methoxy-2-Methyllenzoyl Chloride (MMBC) 10.74 4-(2-Methoxyethyl) Phenol (4MEP) 16.01 Bifenthrin Alcohol (BFA) 15.18 Specialty Chemicals 0 Pharmaceuticals 0 4`-Methyl-2-Cyanobiphenyl (OTBN) 0 CRAMS 0 0 Pharma Intermediates 0 Thiophene-2-Ethanol (T2E) 0 Others 58.07
Location Wise Break-Up	Location Wise Break-Up India 44.0 Finland 18.6 Italy 14.2 China 3.9 Germany 3.4 Spain 2.5 Israel 1.9 France 0 North America 0 LAC 0 Europe 0 Japan 0 Netherlands 0 Belgium 0 USA 0 Others 11.5	Location Wise Break-Up Germany 0 Japan 0 Finland 0 France 0 India 0 Netherlands 0 Israel 0 Latin America 21.0 USA 0 Belgium 0 Europe 40.0 North America 3.0 China 0 Spain 0 Italy 0 Others 36.0	Location Wise Break-Up Germany 7.24 Japan 3.51 Finland 0 France 0 India 64.05 Netherlands 0.93 Israel 0 LAC 0 USA 5.73 Belgium 0 Europe 0 North America 0 China 0.75 Spain 3.89 Italy 10.78 Others 3.12
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-depressant 27.99 Anti-retroviral 21.36 Anti-coagulant 6.73 Anti-malarial 0 Anti-allergic 0 Anti-Asthmatic 0 Vitamins 0 Anti-histamine 0 Analgesic/Anesthetic 0 Others 43.92	Therapeutic Area Break-Up Vitamins 10.0 Anti-allergic 4.0 Anti-histamine 12.0 Anti-coagulant 0 Anti-retroviral 0 Anti-depressant 0 Anti-Asthmatic 4.0 Analgesic/Anesthetic 60.0 Anti-malarial 0 Others 10.0	-
Verticals	Verticals Oil & Gas 0 Photography 0 Coatings 0 Material Science 0 Agro 0 Pharma 0 Others 100	-	Verticals Agro 11.2 Coatings 4.1 Oil & Gas 4.3 Photography 7.6 Material Science 9.8 Pharma 47.5 Others 15.5
Acute vs Chronic	Acute vs Chronic Chronic 95.0 Acute 5.0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 86.96 Others 13.04	-	-
API Break-Up	API Break-Up Trazodone 25.5 Dolutegravir 24.15 Oxcarbamazepine 6.69 Vortioxetine 4.87 Nintedanib 4.51 Zonisamide / Warfarin 4.29 Entacapone 3.52 Darulutamide 2.88 Celecoxib 2.81 Diclofenac Sodium 2.76 Quetiapine 2.63 Rivaroxaban 1.17 Dabigatran 1.02 Pazopanib 0.98 Apixaban 0.88 Others 11.34	-	-

AMI Organics Ltd.

SIGN UP FOR FREE